1. Griffith HR, Johnson GE. The use of curare in general anesthesia. Anesthesiology 1942; 3: 418-20.
2. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery: based on a study of 599, 548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954; 140: 2-35.
3. Christie TH, Churchill-Davidson HC. The St. Thomas’s Hospital nerve stimulator in the diagnosis of prolonged apnoea. Lancet 1958; 1: 776.
4. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. I. Br J Anaesth 1971; 43: 473-7.
7. Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992; 36: 710-5.
9. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103.
12. Lee JS, Han SY, Cho SH, Chung JW, Kim SH, Chai WS, et al. Postoperative residual curarization in the recovery room after vecuronium or rocuronium use. Anesth Pain Med 2006; 1: 101-5.
13. Lee JS, Gong HY, Cho SH, Kim SH, Chai WS, Jin HC. Validity and reliability of head lift and tongue depressor test for diagnosis of the residual block. Anesth Pain Med 2009; 4: 146-50.
14. Mortensen CR, Berg H, el-Mahdy A, Viby-Mogensen J. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol Scand 1995; 39: 797-801.
16. Seo HJ, Lee YK, Lee SS, Kim KS, Yang HS. A survey of postoperative residual neuromuscular block and neuromuscular monitoring. Anesth Pain Med 2010; 5: 70-4.
17. Fruergaard K, Viby-Mogensen J, Berg H, el-Mahdy AM. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 1998; 42: 1168-74.
18. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 120-8.
23. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808.
25. Brull SJ, Silverman DG. Real time versus slow-motion train-of-four monitoring: a theory to explain the inaccuracy of visual assessment. Anesth Analg 1995; 80: 548-51.
28. Michaud G, Trager G, Deschamps S, Hemmerling TM. Dominance of the hand does not change the phonomyographic measurement of neuromuscular block at the adductor pollicis muscle. Anesth Analg 2005; 100: 718-21.
31. Kim KS, Jeon JW, Koh MS, Shim JH, Cho SY, Suh JK. The duration of immobilization causes the changing pharmacodynamics of mivacurium and rocuronium in rabbits. Anesth Analg 2003; 96: 438-42.
33. Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia 2014; 69: 1251-7.
35. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-51.
36. Ledowski T, Ong JS, Flett T. Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice. Anesthesiol Res Pract 2015; 2015: 367-937.
37. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia 2011; 66: 721-5.
38. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111: 110-9.
40. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007; 62: 806-9.
43. Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, et al. Recommendations for standards of monitoring during anaesthesia and recovery. 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71: 85-93.